Floatz logo

Cefepime

Plasma Cell Neoplasm

Wake Forest University Health SciencesSmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

21 Active assets in the Plasma Cell Neoplasm cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Hellenic Society of Hematology
Phase 3BBB
cc-5013
Hellenic Society of Hematology
Phase 3BBB
Cyclophosphamide
Affiliated Hospital to Academy of Military Medical Sciences
Phase 3BB
Fludarabine
Affiliated Hospital to Academy of Military Medical Sciences
Phase 3BB
Fludarabine
Affiliated Hospital to Academy of Military Medical Sciences
Phase 3BB

View all 50 →

Same molecule, other indications

Cefepime is also rated in:

neutropeniaDormant
BB
Indicative ·
70 / 100
View asset →
Pediatric CancerDormant
B
Indicative ·
62 / 100
View asset →
Invasive Bacterial InfectionDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →